Clinical trial
Levosimendan Versus Dobutamine for Renal Function in Heart Failure
NCT02133105
Study timeline
Study start (actual)2014-04-01Date precision: month
Registry last updated2020-02-25
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Cardiorenal Syndromeunresolved
Interventions
LevosimendanDRUG
DobutamineDRUG
Sponsors & collaborators
Göteborg Universitylead sponsor
Sahlgrenska University Hospitalcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02133105 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.